Supernus Pharmaceuticals | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Abbott USD 5.92B 114M 2025-03
ANI Pharmaceuticals USD 124.08M 13.79M 2025-03
Aurora Cannabis CAD 9.35M 6.18M 2024-12
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Canopy Growth CAD 24.1M 2.26M 2024-12
Corcept Therapeutics USD 154.81M 24.12M 2025-03
Eisai JPY 147.63B 22.57B 2025-03
Eli Lilly USD 10.5B 624.7M 2025-03
Indivior 222M 54M 2025-03
Novo Nordisk 65.2B 5.19B 2025-03
Pacira USD 134.62M 12.75M 2025-03
Perrigo USD 385.9M 18.5M 2024-12
Pfizer USD 11.12B 987M 2025-03
Supernus Pharmaceuticals USD 156.96M 1.14M 2024-12
United Therapeutics USD 701.9M 41.9M 2025-03
Xeris Pharmaceuticals USD 50.62M 9.95M 2024-12



Supernus Pharmaceuticals Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.